4//SEC Filing
Kewalramani Reshma 4
Accession 0000875320-24-000156
CIK 0000875320other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:21 PM ET
Size
4.7 KB
Accession
0000875320-24-000156
Insider Transaction Report
Form 4
Kewalramani Reshma
DirectorCEO & President
Transactions
- Sale
Common Stock
2024-05-20$447.00/sh−15,202$6,795,294→ 121,374 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 02/07/2024.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001735944
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:21 PM ET
- Size
- 4.7 KB